MPPE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.47610000281284E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.24980000021569E-07 |
Normal-vs-Stage2 |
1.595970E-03 |
Normal-vs-Stage3 |
1.1798000354446E-09 |
Normal-vs-Stage4 |
7.28210003408947E-09 |
Stage1-vs-Stage2 |
2.255800E-01 |
Stage1-vs-Stage3 |
1.809990E-02 |
Stage1-vs-Stage4 |
5.788300E-02 |
Stage2-vs-Stage3 |
7.084300E-03 |
Stage2-vs-Stage4 |
1.824260E-02 |
Stage3-vs-Stage4 |
8.867600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.92679999627887E-09 |
Normal-vs-AfricanAmerican |
4.133700E-02 |
Normal-vs-Asian |
6.678300E-02 |
Caucasian-vs-AfricanAmerican |
5.396900E-03 |
Caucasian-vs-Asian |
6.897600E-01 |
AfricanAmerican-vs-Asian |
4.282000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.95499974384472E-10 |
Normal-vs-Female |
1.241750E-04 |
Male-vs-Female |
8.95580000048746E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.46399997364477E-09 |
Normal-vs-Age(41-60Yrs) |
1.54940000052228E-07 |
Normal-vs-Age(61-80Yrs) |
3.0719000010393E-08 |
Normal-vs-Age(81-100Yrs) |
1.540400E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.292300E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.779700E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.078000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.855000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.113600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.800400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.862800E-01 |
Normal-vs-Grade 2 |
4.75250000020466E-07 |
Normal-vs-Grade 3 |
7.02739999525193E-08 |
Normal-vs-Grade 4 |
1.69309011255336E-12 |
Grade 1-vs-Grade 2 |
2.210400E-01 |
Grade 1-vs-Grade 3 |
1.622390E-01 |
Grade 1-vs-Grade 4 |
2.318000E-02 |
Grade 2-vs-Grade 3 |
3.779400E-01 |
Grade 2-vs-Grade 4 |
1.9094999999969E-05 |
Grade 3-vs-Grade 4 |
4.009100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.06259999999681E-05 |
Normal-vs-ccB subtype |
2.54130050336698E-11 |
ccA subtype-vs-ccB subtype |
4.7512000000971E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.74380000228913E-08 |
Normal-vs-N1 |
7.182300E-04 |
N0-vs-N1 |
3.262800E-01 |
|
|